9
49
Growth Score 9 in past quarter
-2 pts
Heat Score 49 in past quarter
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
298724
Centillion is a biotechnology company, specialist in accelerating drug discovery & development with its RNA-By-Design manufacturing platform
- Chris Frampton: Director & Chief Scientific OfficerPast Role: Nuformix, Co-founder and scientific advisor
About the Company
Centillion is the Biofoundry-in-a-Box(TM) company, our digitally enabled RNA-By-Design(TM) manufacturing platform. Centillion works with RNA innovators developing therapies or vaccines, and CDMOs to accelerate development pipelines from concept to the patient. Centillion’s BiaB(TM) platform technology ensures the seamless transition from discovery
to manufacturing at scale, reducing risk and help innovators achieve development milestones from early stage discovery through to market authorisation. Centillion’s mission is to accelerate equitable access to RNA-based therapies and vaccines, providing a robust and sustainable response to unmet clinical needs for everyone, everywhere.